首页 | 官方网站   微博 | 高级检索  
     

甘精胰岛素不同给药时间治疗1型糖尿病的疗效及安全性研究
引用本文:李颖.甘精胰岛素不同给药时间治疗1型糖尿病的疗效及安全性研究[J].中国基层医药,2014(15):2310-2311.
作者姓名:李颖
作者单位:秦皇岛市山海关区人民医院内分泌科,河北省秦皇岛066200
摘    要:目的:探讨不同时间皮下注射甘精胰岛素治疗1型糖尿病的疗效及安全性。方法选取50例1型糖尿病患者,应用门冬胰岛素联合甘精胰岛素进行治疗,在甘精胰岛素不改变用量前提下,给药时间由22:00调整到18:00前后,比较时间调整前后3 d患者空腹血糖( FBG)、早中晚餐后2 h血糖(2hPG)和午餐前血糖的变化情况、门冬胰岛素的用量及午餐前患者低血糖事件发生情况。结果甘精胰岛素调整用药时间后,患者午餐前血糖调整至理想水平,FBG(7.28±2.13)mmol/L比(8.33±2.20)mmol/L、午餐后2hPG下降显著(8.61±2.59)mmol/L 比(9.70±1.75)mmol/L(U=2.425、3.034,均 P<0.05),早餐后2hPG (8.27±2.02)mmol/L比(8.56±2.33)mmol/L和晚餐后2hPG(9.54±1.55)mmol/L比(9.61±1.75)mmol/L变化均不明显(均P>0.05);门冬胰岛素早餐前用量减少,午餐前和晚餐前用量增加;午餐前低血糖事件显著减少(χ2=4.105、5.005,均P<0.05)。结论甘精胰岛素联合门冬胰岛素治疗1型糖尿病患者,在不改变甘精胰岛素用量情况下,给药时间由22:00调整为18:00,可平稳降低空腹血糖,减少午餐前低血糖的发生。

关 键 词:糖尿病  1型  甘精胰岛素

Research on the efficacy and safety of insulin glargine in different administration time for treatment of type 1 diabetes
Li Ying.Research on the efficacy and safety of insulin glargine in different administration time for treatment of type 1 diabetes[J].Chinese Journal of Primary Medicine and Pharmacy,2014(15):2310-2311.
Authors:Li Ying
Affiliation:Li Ying (Department of Endocrinology, the People's Hospital of Shanhaiguan District, Qinhuangdao , Hebei 066200, China)
Abstract:Objective To explore the clinical efficacy and safety of insulin glargine in different administra-tion time for treatment of type 1 diabetes .Methods 50 patients with type 1 diabetes were given insulin aspart and in-sulin glargine treatment scheme , under the premise of not change insulin glargine dosage , delivery time of insulin glargine varied from 22:00 to 18:00,and fasting blood glucose(FBG),2 hours postprandial blood glucose(2hPG), blood glucose and occurrence of hypoglycemia before lunch , amount of insulin aspart were noted and compared between before and after the adjustment .Results After adjustment of insulin glargine′s medication time , patients′blood sugar before lunch adjusted to desired level ,FBG(7.28 ±2.13) mmol/L vs.(8.33 ±2.20) mmol/L,2hPG (8.61 ±2.59)mmol/L vs.(9.70 ±1.75) mmol/L decreased significantly after lunch compared with pre-adjustment (U=2.425,3.034,all P〈0.05),2hPG after breakfast (8.27 ±2.02) mmol/L vs.(8.56 ±2.33) mmol/L and dinner 2hPG (9.54 ±1.55)mmol/L vs.(9.61 ±1.75)mmol/L without statistically significant difference (all P〉0.05).Dosage of insulin aspart before breakfast reduced , and increased before lunch and dinner .Incidence of hypoglycemia before lunch significantly decreased (χ2 =4.105,5.005,all P〈0.05).Conclusion Insulin glargine combined with insulin aspart in the treatment of type I diabetes ,with no change in insulin glargine dosage ,and delivery time changed from 22:00 to 18:00,which could reduce FBG ,reduce occurrence of hypoglycemia before lunch ,and stable in blood sugar controlling .
Keywords:Diabetes mellitus  type 1  Insulin glargine
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号